The cyclosporins inhibit lymphocyte activation at more than one site

• Published in: The Journal of immunology (1950) Vol. 138; no. 4; pp. 1115 - 1120
• Main Authors: Gelfand, EW, Cheung, RK, Mills, GB
• Format: Journal Article
• Language: English
• Published: Bethesda, MD Am Assoc Immnol 15.02.1987; American Association of Immunologists
• Subjects: Biological and medical sciences; Calcium - analysis; Cell Division - drug effects; Cyclosporine; Cyclosporins - pharmacology; Cytosol - analysis; Humans; Immunomodulators; Lymphocyte Activation - drug effects; Medical sciences; Membrane Potentials - drug effects; Pharmacology. Drug treatments; Phytohemagglutinins - pharmacology; T-Lymphocytes - drug effects; Human; In vivo; T-Lymphocyte; Activation; Immunosuppressive agent; Inhibition; Membrane potential; Mechanism of action; In vitro; Biological activity
• ISSN: 0022-1767; 1550-6606
• DOI: 10.4049/jimmunol.138.4.1115

Cyclosporin A (CsA), a potent immunosuppressive agent, acts primarily by inhibiting T cell function. Although several potential sites of action have been identified, the mechanisms whereby CsA mediates its immunosuppressive properties have not been fully delineated. We have examined the effects of the immunosuppressive cyclosporins, CsA, dihydrocyclosporin D, and cyclosporin G, and a nonimmunosuppressive analog, cyclosporin H, on early events associated with activation of human T cells. Interleukin 2 (IL 2) receptor expression, as measured by immunofluorescence, was unaffected by CsA. Despite this, in the continuous presence of CsA, exogenous IL 2 did not bypass CsA inhibition of phytohemagglutinin (PHA)-induced proliferation. Thus, one site of activity of CsA is on IL 2-induced proliferation of IL 2 receptor-expressing cells. In addition, several potential mechanisms for inhibiting IL 2 secretion were identified. Changes in cytosolic free Ca2+ ([Ca2+]i), an obligatory event for PHA-induced IL 2 secretion, were inhibited by a 30-min preincubation with the immunosuppressive cyclosporins but not the inactive analog. In this action, the drug effects cannot be distinguished from that of Ca2+ channel blockers. The active compounds also resulted in membrane depolarization, an effect which may, in part, explain the reduction in PHA-induced changes in [Ca2+]i. These results identify multiple sites of action of the immunosuppressive cyclosporins, the combination of which likely accounts for their selective inhibition of T cell function in vitro and in vivo.